Vanderbilt Institute for Clinical and Translational Research
Nationwide Children's Hospital
Institute of Clinical and Translational Sciences
CSL Behring
Seattle Children's Research Institute
Children's Mercy Hospital
Children’s Hospital of Wisconsin Research Institute
Vanderbilt University Medical Center
Moderna
Horizon Therapeutics
Astellas Pharma
SymBio Pharmaceuticals Limited
National Institutes of Health
Centers for Disease Control and Prevention
Sanofi Pasteur
National Institute of Allergy and Infectious Diseases
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season
Andrew J. Spieker, Claire Bocchini, Tess Stopczynski, Jennifer E. Schuster et al.
Citations
4 citations
Journal
The Journal of Infectious Diseases
Topics
Influenza Virus Research Studies
Field-Weighted Citation Impact (FWCI)
1.55
article
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season
Andrew J. Spieker, Claire Bocchini, Tess Stopczynski, Jennifer E. Schuster, Hannah Bahakel, Molly Potter, Paul A. Carpenter, Justin Z. Amarin, Jason Lawrence Freedman, Grant Paulsen, Elizabeth A. Moulton, Flor M. Muñoz, Natasha Halasa, Kim Allison, Susan Coffin, Michael Grimley, Christopher J. Harrison, Zaid Haddadin, Christopher T. Williams, Herdi Rahman, Christopher C. Dvorak, Rachel L Wattier, Monica I. Ardura, Anna Stahl, Samantha Blum, Lauren G. Shoemaker, Einas Batarseh, Shari Barto, Laura S Stewart, Spyros A. Kalams, Gabriela Marón, Carrie L. Kitko, Janet A. Englund, Lara Danziger‐Isakov, Rendie McHenry, Haya Hayek, Michael F Russo, Kenny Truong, Daniel E. Dulek, Hannah Smith, Rakesh Goyal, Margaret Bender, Kirsten Lacombe, Lubna Hamdan, Swati Naik
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Infectious DiseasesVol. 231(1)
Institutions
Cincinnati Children's Hospital Medical Center (US), Seattle Children's Hospital (US), Monroe Carell Jr. Children's Hospital (US), St. Jude Children's Research Hospital (US), Nationwide Children's Hospital (US), Children's Mercy Hospital (US), Children's Hospital of Philadelphia (US), University of California, San Francisco (US), Baylor College of Medicine (US), University of Washington (US), Texas Children's Hospital (US), University of Cincinnati (US), Vanderbilt University Medical Center (US)
Funders
Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Pediatric Infectious Diseases Society, Children's Hospital of Philadelphia, Vanderbilt University, Texas Children's Hospital, Cincinnati Children's Hospital Medical Center, Vanderbilt Institute for Clinical and Translational Research, Nationwide Children's Hospital, Institute of Clinical and Translational Sciences, CSL Behring, Seattle Children's Research Institute, Children's Mercy Hospital, Children’s Hospital of Wisconsin Research Institute, Vanderbilt University Medical Center, Moderna, Horizon Therapeutics, Astellas Pharma, SymBio Pharmaceuticals Limited, National Institutes of Health, Centers for Disease Control and Prevention, Sanofi Pasteur, National Institute of Allergy and Infectious Diseases